Stéphane Picard
Impact in
- Hematology top 2%
- Chronic Myeloid Leukemia Treatments
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research
Papers in
- Genetics 5
- Chronic Lymphocytic Leukemia Research 5
-
- Chronic Myeloid Leukemia Treatments 5
- Co-authors
- Mathiéu Molimard (5 shared papers)François‐Xavier Mahon (5 shared papers)Nicholas Moore (3 shared papers)Karine Titier (4 shared papers)Dominique Ducint (3 shared papers)Gérald Marit (4 shared papers)R. Lassalle (2 shared papers)Bernard Bégaud (2 shared papers)
- Journals
- Blood (4 papers)Therapeutic Drug Monitoring (1 paper)Oncology Reports (1 paper)Journal of Cancer Research and Clinical Oncology (1 paper)PubMed (1 paper)
- Partner nations
- France
In The Last Decade
Stéphane Picard
8 papers receiving 601 citations
Peers
Comparison fields: 5 of 56
- Hematology 480
- Genetics 397
- Rheumatology 240
- Gastroenterology 47
- Oncology 89
Countries citing papers authored by Stéphane Picard
This map shows the geographic impact of Stéphane Picard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stéphane Picard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stéphane Picard more than expected).
Fields of papers citing papers by Stéphane Picard
This network shows the impact of papers produced by Stéphane Picard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stéphane Picard. The network helps show where Stéphane Picard may publish in the future.
Co-authors
The 24 scholars most cited alongside Stéphane Picard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 468 | |
| 2 | 2005 | 84 | |
| 3 | 2017 | 30 | |
| 4 | Absence of genetic abnormalities in fibroadenomas of the breast determined at p53 gene mutations and microsatellite alterations. | 2001 | 15 |
| 5 | 2007 | 7 | |
| 6 | 2002 | 4 | |
| 7 | 2006 | 4 | |
| 8 | 2005 | 1 |
About Stéphane Picard
Stéphane Picard is a scholar working on Genetics, Hematology, Rheumatology, Pathology and Forensic Medicine and Infectious Diseases, having authored 8 papers that have together received 613 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (5 papers), Chronic Lymphocytic Leukemia Research (5 papers), Eosinophilic Disorders and Syndromes (4 papers), Cancer and Skin Lesions (1 paper), Cancer Genomics and Diagnostics (1 paper), Genetic factors in colorectal cancer (1 paper), Pneumocystis jirovecii pneumonia detection and treatment (1 paper) and Antifungal resistance and susceptibility (1 paper). The work is most often cited by research in Hematology (480 citations), Genetics (397 citations), Rheumatology (240 citations), Gastroenterology (47 citations) and Oncology (89 citations). Stéphane Picard has collaborated with scholars based in France. Frequent co-authors include Mathiéu Molimard, François‐Xavier Mahon, Nicholas Moore, Karine Titier, Dominique Ducint, Gérald Marit, R. Lassalle, Bernard Bégaud, Josy Reiffers and Marie‐Agnès Bernard. Their work appears in journals such as Blood, Therapeutic Drug Monitoring, Oncology Reports, Journal of Cancer Research and Clinical Oncology and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.